Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe gastrointestinal side effects of semaglutide are real, common, and for most people, manageable. Nausea is the one everyone hears about, but the full picture includes vomiting, diarrhoea, constipation, indigestion, acid reflux and burping — typically peaking in the first days after a new dose or a dose increase, then fading as the body adjusts. These are prescription-only medicines assessed by a clinician before treatment starts; a prescriber weighs this profile against your individual circumstances as part of that process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Plenty of people stop treatment early because they assume nausea means something is wrong. In fact, the opposite is often true. Semaglutide slows gastric emptying, food leaves the stomach more gradually than usual, which directly reduces appetite and calorie intake. That same mechanism is why your stomach can protest, especially in the early weeks. The sensation is the drug doing exactly what it is supposed to do; the body simply hasn't calibrated yet.
The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, burping and indigestion as common effects, common meaning they affect more than one in ten people at some stage. That statistic is worth sitting with. These are not rare or unexpected; they are built into the licensed profile of the medicine, and the titration schedule (starting low and stepping up gradually) exists precisely to reduce their intensity.
What this means practically: if you feel queasy after your first pen, that is not a signal to stop. It is a signal to eat smaller meals, avoid fatty or spiced food for a few days, stay well hydrated, and let a few days pass. Many people find the nausea barely registers by the time they reach their second or third dose. For broader context on the full side-effect profile, our overview of semaglutide side effects covers what the evidence says across the treatment period.
Nausea is the headline, but the gastrointestinal effects people experience from semaglutide span a wider range depending on the individual and the stage of treatment. The pattern the NHS and clinical trials describe consistently is this: symptoms are most noticeable at the start of treatment and after each dose step-up, then gradually settle over days to two weeks.
Nausea and vomiting tend to be worst in the 24 to 48 hours immediately after an injection. Diarrhoea and constipation can alternate or appear independently. Acid reflux and indigestion are more common at higher doses. Burping (occasionally caught off guard) is reported frequently and is a direct result of slowed gastric emptying. Fatigue can accompany GI symptoms, particularly if appetite suppression leads to reduced food intake without adequate attention to protein and hydration.
A few practical points that people find useful: eating slowly and stopping before feeling full reduces nausea considerably. Cold or room-temperature foods tend to be better tolerated than hot, strongly flavoured meals. Keeping meals smaller and more frequent rather than eating large portions helps. If you have a dose increase scheduled, timing it to coincide with a quieter few days is sensible, some people plan around a long weekend rather than the working week, in the same way you might time a new antibiotic. Our page on Wegovy side effects covers the injection-specific side-effect picture in more detail.
Constipation specifically responds well to increased fluid intake and dietary fibre. Laxatives may be discussed with a prescriber if it becomes a recurring issue. The Mounjaro and Wegovy SmPCs on the eMC carry detailed frequency breakdowns for each reported effect, worth reading alongside your patient information leaflet.
Most GI side effects are self-limiting and manageable at home. A few are not. Knowing the difference matters.
Seek urgent medical attention if you experience severe stomach pain that radiates to your back, with or without vomiting. This is the presentation the MHRA specifically flagged in its January 2026 Drug Safety Update on GLP-1 receptor agonist medicines, identifying acute pancreatitis as a known but infrequent side effect that can be serious. It is not common, but it is the side effect that should not be waited out at home.
Similarly, if persistent vomiting or diarrhoea leads to dehydration (signs include dark urine, dizziness, rapid heartbeat, or being unable to keep fluids down for more than a day) contact a GP or urgent care. Dehydration can strain the kidneys, particularly if you take other medicines that affect kidney function. Understanding which side effects of semaglutide are considered serious can help you decide when to act quickly rather than wait and see. An allergic reaction (swelling of the face, throat, or tongue; difficulty breathing; a widespread rash) requires emergency treatment immediately.
Gallbladder problems, including gallstones, are more common during significant weight loss generally, not just on GLP-1 medicines. Severe pain in the upper right abdomen, especially after eating, should be assessed by a doctor. If you experience any side effects you are unsure about, the MHRA's Yellow Card scheme allows you and your healthcare team to report them, contributing to the ongoing safety monitoring of these medicines. You can also raise concerns directly through our aftercare team, who are available seven days a week.
Some people experience GI side effects that settle within a few weeks and then barely recur. Others find they return briefly with each dose increase before settling again. A smaller number find the symptoms persistent enough to affect daily life, in which case the prescriber may recommend slowing the titration schedule, holding at a lower dose for longer, or assessing whether treatment is still appropriate.
The question of how long semaglutide side effects last is one our prescribers hear regularly; the honest answer is that the timeline varies, but persistent severe symptoms beyond the first couple of weeks at any given dose are worth discussing rather than tolerating silently.
Protein adequacy deserves a mention here. Reduced appetite is the point of treatment, but eating too little protein while also experiencing nausea can compound fatigue and muscle loss. Even when appetite is suppressed, aiming to maintain protein intake at each meal is worth prioritising, and understanding each side effect of semaglutide in context can make it easier to spot when something needs attention rather than simply riding it out. A prescriber or dietitian can give personalised guidance on this, it is part of the clinical conversation, not an afterthought.
Semaglutide (Wegovy) is a prescription-only medicine. Our prescribers discuss the full side-effect profile, your individual health picture and any medicines you already take as part of the consultation. If you are thinking about treatment, starting a free consultation is the first step, no commitment, reviewed the same day by a registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.